Dri Healthcare Trust T.DHT.UN

Alternate Symbol(s): DHTRF

Healthcare Biotechnology

DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term. Geographically, it has a presence in the United States; European Union; Japan, and Rest of the world.

TSX:DHT.UN - Post by User

Dri Healthcare Trust

<< Previous

Bullboard Posts

Next >>

Post by retiredcfon Jul 22, 2022 9:20am

195 Views

Post# 34842685

Upgrade

After DRI Healthcare Trust announced Thursday the acquisition of a royalty interest in the global sales of pegcetacoplan for the treatment of paroxysmal nocturnal hemoglobinuria for $24.5-million, Canaccord Genuity’s Tania Armstrong-Whitworth raised her target for its shares to $15 from $14.50, which is the current consensus. She reiterated a “buy” rating.

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide